TAKEDA PHARMACEUTICAL CO LTD
The Takeda Pharmaceutical Company Limited (武田薬品工業株式会社, Takeda Yakuhin Kōgyō kabushiki gaisha) [takeꜜda jakɯçiŋ koꜜːɡʲoː] is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue (top 10 following its merger with Shire). The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. In 2026, Julie Kim was noted in a news item as "CEO-elect".
Basic company information
Each field links to its source. Financial figures retain their reporting periods; background references are identified in the source list.
- Ticker / security symbols
- TAK, TKPHF [1]
- Listing exchanges
- NYSE, OTC [1]
- SEC industry
- Pharmaceutical Preparations [1]
- Business sectors
- pharmaceutical industry [2]
- Company / filing name
- TAKEDA PHARMACEUTICAL CO LTD [1]
- Headquarters location
- Osaka; Chūō-ku [2]
- Business address
- 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU, TOKYO, M0, 103-8668 [1]
- Founded
- 1781-08-01 [2]
- Legal form
- kabushiki gaisha [2]
- Founders
- Takeda Chōbei I [2]
- Official website
- www.takeda.co.jp ↗ [2]
- ISIN (reported securities)
- US8740602052; JP3463000004 [2]
- CIK
- 0001395064 [1]
- SIC code
- 2834 [1]
- Country in background record
- Japan [2]
Company positioning and business
The Takeda Pharmaceutical Company Limited (武田薬品工業株式会社, Takeda Yakuhin Kōgyō kabushiki gaisha) [takeꜜda jakɯçiŋ koꜜːɡʲoː] is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue (top 10 following its merger with Shire). The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. In 2026, Julie Kim was noted in a news item as "CEO-elect". [3]
Background text: Wikipedia contributors, Takeda Pharmaceutical Company. Selected introductory paragraphs, licensed under CC BY-SA 4.0. Official filing data is cited separately.
Financial year, securities and disclosures
Listed securities: TAK (NYSE), TKPHF (OTC). Multiple symbols may represent different share classes or securities of the same registrant. [4]
History and key events
Financial results and regulatory disclosures
Annual, quarterly and current reports from the collected SEC record. Insider Forms 4 and 144 are excluded. This is a selected list, not a live filing feed.
Source-verified relationships
Companies in the same industry
Comparison candidates share the SEC SIC classification 2834. This does not imply ownership, partnership or trading relationships.
Related entities and concepts
Frequently asked questions
When was TAKEDA PHARMACEUTICAL CO LTD founded?
Founded: 1781-08-01. The linked source provides the background record. [2]
Where is the headquarters of TAKEDA PHARMACEUTICAL CO LTD?
Headquarters location: Osaka; Chūō-ku. The linked source provides the background record. [2]
Which business sectors are recorded for TAKEDA PHARMACEUTICAL CO LTD?
Business sectors: pharmaceutical industry. The linked source provides the background record. [2]
TAKEDA PHARMACEUTICAL CO LTD relationship map
Select a node to inspect its relationship and source.
3 verified direct relationships. Industry peers are not relationship edges.
Sources and review dates
- SEC — TAKEDA PHARMACEUTICAL CO LTD filing identity and securities ↗
- Wikidata — company background record (CC0) ↗
- Wikipedia contributors — Takeda Pharmaceutical Company (CC BY-SA 4.0) ↗
- SEC securities directory ↗
- Company chronology / filing ↗
Reviewed 23 October 2026. Financial periods and historical event dates are shown separately. Figures reflect their stated source dates; this page is not a live quote or investment recommendation.